Addentax COO granted 66,667 shares in equity plan

Wu Rui reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 04/10/2026 - 04:18 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Wu Rui reported acquisition or exercise transactions in this Form 4 filing.

Addentax Group Corp. granted Chief Operating Officer Wu Rui 66,667 shares of common stock. The shares were awarded at a price of $0.00 per share under the Addentax Group Corp. 2024 Equity Incentive Plan, bringing Wu Rui’s direct holdings to 66,667 shares.

The grant was approved by the Compensation Committee on March 24, 2026, and the award agreement was executed on April 8, 2026, the same date reported for the transaction.

Insider Trade Summary

Grant/Award: 66,667 shares

Grant/Award 1 txn

Insider Wu Rui

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	66,667	$0.00	$0.00

Holdings After Transaction: Common Stock — 66,667 shares (Direct)

Holdings Before and After: Common Stock, 0 to 66,667 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock granted to the reporting person pursuant to the Addentax Group Corp. 2024 Equity Incentive Plan. The grant was approved by the Compensation Committee on March 24, 2026, and the award agreement was executed on April 8, 2026.

Key Figures

Shares granted: 66,667 shares Grant price: $0.00 per share Holdings after grant: 66,667 shares +3 more

6 metrics

Shares granted 66,667 shares Common stock grant to COO Wu Rui on April 8, 2026

Grant price $0.00 per share Stated transaction price for equity award

Holdings after grant 66,667 shares Total common shares directly held by Wu Rui after transaction

Plan name Addentax Group Corp. 2024 Equity Incentive Plan Plan under which the 66,667-share grant was made

Committee approval date March 24, 2026 Compensation Committee approval of the grant

Award execution date April 8, 2026 Award agreement execution and transaction date

Key Terms

2024 Equity Incentive Plan, Compensation Committee, grant/award acquisition, Form 4

4 terms

2024 Equity Incentive Plan financial

"granted to the reporting person pursuant to the Addentax Group Corp. 2024 Equity Incentive Plan"

Compensation Committee financial

"The grant was approved by the Compensation Committee on March 24, 2026"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

grant/award acquisition financial

"transaction_action: grant/award acquisition with code A for the common stock"

Form 4 regulatory

"INSIDER FILING DATA (Form 4): transaction reported for Wu Rui"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Addentax Group Corp. (ATXG) report for Wu Rui?

Addentax reported that Chief Operating Officer Wu Rui received 66,667 shares of common stock as a grant. The award was made under the company’s 2024 Equity Incentive Plan at a stated price of $0.00 per share, increasing direct holdings to 66,667 shares.

Was the Addentax (ATXG) Form 4 transaction a purchase or a grant?

The Form 4 shows a grant/award acquisition, not an open-market purchase. Wu Rui received 66,667 common shares at $0.00 per share as equity compensation under the 2024 Equity Incentive Plan, rather than buying shares in the market.

How many Addentax (ATXG) shares does Wu Rui hold after this Form 4 grant?

After the reported grant, Wu Rui directly holds 66,667 shares of Addentax common stock. The entire position shown in this filing comes from the single equity award reported, with no additional derivative positions disclosed in the accompanying data.

Under which plan was Wu Rui’s Addentax (ATXG) stock grant made?

The shares were granted under the Addentax Group Corp. 2024 Equity Incentive Plan. This plan is used to award equity compensation, and the Form 4 specifies that the 66,667-share grant to Wu Rui was made pursuant to this plan.

When was Wu Rui’s Addentax (ATXG) equity award approved and executed?

The grant was approved by the Compensation Committee on March 24, 2026, according to the footnote. The related award agreement was then executed on April 8, 2026, which is also the transaction date reported in the Form 4 data.

Does the Addentax (ATXG) Form 4 for Wu Rui involve any derivative securities?

The provided filing data indicates no derivative securities for this transaction. It shows a single non-derivative common stock grant of 66,667 shares, and the derivative position summary is empty, meaning no options or similar instruments are listed here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wu Rui

(Last) (First) (Middle)

KINGKEY 100, BLOCK A,

ROOM 4805, LUOHU DISTRICT

(Street)

SHENZHEN 518000

(City) (State) (Zip)

CHINA

(Country)

2. Issuer Name and Ticker or Trading Symbol
ADDENTAX GROUP CORP. [ ATXG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/08/2026		A		66,667(1)	A	$0	66,667	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock granted to the reporting person pursuant to the Addentax Group Corp. 2024 Equity Incentive Plan. The grant was approved by the Compensation Committee on March 24, 2026, and the award agreement was executed on April 8, 2026.

	/s/ Rui Wu	04/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)